X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (373) 373
basal ganglia (265) 265
male (257) 257
female (229) 229
index medicus (223) 223
clinical neurology (178) 178
aged (165) 165
neurosciences (161) 161
middle aged (156) 156
adult (110) 110
magnetic resonance imaging (109) 109
neurology (100) 100
brain (92) 92
parkinson's disease (89) 89
psychiatry (81) 81
animals (67) 67
movement disorders (64) 64
aged, 80 and over (60) 60
stroke (60) 60
dementia (56) 56
neuroimaging (56) 56
treatment outcome (54) 54
risk factors (51) 51
parkinsons-disease (48) 48
diagnosis (47) 47
health aspects (42) 42
dopamine (41) 41
patients (41) 41
brain - pathology (40) 40
care and treatment (40) 40
neurodegenerative diseases (40) 40
disease (39) 39
alzheimers-disease (38) 38
central nervous system diseases (37) 37
research (37) 37
ganglia (34) 34
parkinson disease - physiopathology (33) 33
rats (33) 33
medicine & public health (32) 32
parkinson disease - drug therapy (32) 32
surgery (32) 32
basal ganglia - pathology (31) 31
cortex (31) 31
analysis (30) 30
basal ganglia diseases - chemically induced (30) 30
parkinsonism (30) 30
brain - physiopathology (29) 29
cognitive ability (29) 29
neuropsychological tests (29) 29
radiology, nuclear medicine & medical imaging (29) 29
adolescent (28) 28
alzheimer's disease (28) 28
lesions (28) 28
brain - diagnostic imaging (27) 27
cerebrovascular circulation - physiology (27) 27
levodopa (27) 27
nervous system (27) 27
parkinsons disease (27) 27
pharmacology & pharmacy (27) 27
thalamus (27) 27
cerebrovascular circulation (26) 26
cerebrovascular circulation - drug effects (26) 26
follow-up studies (26) 26
geriatrics & gerontology (26) 26
levodopa - therapeutic use (26) 26
nervous system diseases (26) 26
physiological aspects (26) 26
retrospective studies (26) 26
child (25) 25
hypertension (25) 25
antipsychotic agents - therapeutic use (24) 24
article (24) 24
cognition (24) 24
medical research (24) 24
mri (24) 24
parkinson disease - diagnostic imaging (24) 24
prospective studies (24) 24
central-nervous-system (23) 23
medical imaging (23) 23
medicine (23) 23
positron emission tomography (23) 23
research article (23) 23
antiparkinson agents - therapeutic use (22) 22
antipsychotic agents - adverse effects (22) 22
cerebral blood flow (22) 22
medicine, experimental (22) 22
nuclear magnetic resonance--nmr (22) 22
age (21) 21
dystonia (21) 21
ischemia (21) 21
peripheral vascular disease (21) 21
studies (21) 21
tomography, emission-computed, single-photon (21) 21
tomography, x-ray computed (21) 21
basal ganglia - blood supply (20) 20
basal ganglia cerebrovascular disease - diagnostic imaging (20) 20
diagnosis, differential (20) 20
drug therapy (20) 20
inflammation (20) 20
intracerebral hemorrhage (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Affective Disorders, ISSN 0165-0327, 2006, Volume 97, Issue 1, pp. 265 - 270
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 04/2004, Volume 75, Issue 4, pp. 545 - 547
Objective: To determine whether a positive l-dopa response in vascular parkinsonism (VP) is correlated with the presence of nigrostriatal pathology due to... 
SURGERY | INFARCTION | TREMOR | PSYCHIATRY | BASAL GANGLIA | DISEASE | STATE | SUBSTANTIA-NIGRA | LESIONS | PET | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | Cerebral Infarction - drug therapy | Neural Pathways - drug effects | Prospective Studies | Substantia Nigra - pathology | Humans | Parkinson Disease, Secondary - diagnosis | Basal Ganglia Cerebrovascular Disease - drug therapy | Cerebral Infarction - diagnosis | Male | Neural Pathways - pathology | Substantia Nigra - blood supply | Microcirculation - drug effects | Antiparkinson Agents - therapeutic use | Parkinson Disease, Secondary - pathology | Dominance, Cerebral - physiology | Parkinson Disease, Secondary - drug therapy | Aged, 80 and over | Female | Cell Death - drug effects | Dominance, Cerebral - drug effects | Corpus Striatum - pathology | Cerebral Infarction - pathology | Neural Pathways - blood supply | Basal Ganglia Cerebrovascular Disease - diagnosis | Levodopa - therapeutic use | Treatment Outcome | Antiparkinson Agents - adverse effects | Substantia Nigra - drug effects | Basal Ganglia Cerebrovascular Disease - pathology | Microcirculation - pathology | Levodopa - adverse effects | Corpus Striatum - drug effects | Neurologic Examination - drug effects | Aged | Corpus Striatum - blood supply | Parkinsonism | Physiological aspects | Research | Paper
Journal Article
Psychiatry and Clinical Neurosciences, ISSN 1323-1316, 02/2005, Volume 59, Issue 1, pp. 109 - 110
Journal Article
Progress in Neuropsychopharmacology & Biological Psychiatry, ISSN 0278-5846, 2004, Volume 28, Issue 7, pp. 1189 - 1194
Journal Article
Journal Article
NeuroImage, ISSN 1053-8119, 05/2012, Volume 61, Issue 1, pp. 228 - 239
Large increases in regional cerebral blood flow (rCBF) have been measured in patients with Parkinson's disease (PD) following the administration of L-DOPA, but... 
Parkinsonism | Cerebrovascular | Levodopa | Astrocyte | Motor complications | Neurovascular coupling | LEVODOPA-INDUCED DYSKINESIAS | UNILATERAL LESIONS | GLUCOSE-UTILIZATION | SUBSTANTIA-NIGRA | AGONISTS | NEUROSCIENCES | NEUROIMAGING | BRAIN-BARRIER DYSFUNCTION | MOTOR FLUCTUATIONS | RECEPTOR SUPERSENSITIVITY | NEURAL MECHANISMS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Tyrosine 3-Monooxygenase - metabolism | Nestin | Antiparkinson Agents - pharmacology | Sympatholytics | Basal Ganglia - metabolism | Benserazide - pharmacology | Oxidopamine | Parkinson Disease, Secondary - drug therapy | Behavior, Animal - drug effects | Female | Parkinson Disease, Secondary - chemically induced | Capillaries - metabolism | Levodopa - pharmacology | Permeability - drug effects | Cerebrovascular Circulation - drug effects | Dyskinesias - physiopathology | Rats | Blood-Brain Barrier - drug effects | Rats, Sprague-Dawley | Nerve Tissue Proteins - metabolism | Autoradiography | Algorithms | Animals | Parkinson Disease, Secondary - physiopathology | Glucose - metabolism | Intermediate Filament Proteins - metabolism | Basal Ganglia - drug effects | Phosphates | Parkinson's disease | Tracers (Biology) | Physiological aspects | Phenols | Diagnostic imaging | Glucose | Movement disorders | Dextrose | Blood flow | Antiparkinsonian agents | Brain | Metabolism | Rodents | Parkinsons disease | neurovascular coupling | cerebrovascular | parkinsonism | levodopa | astrocyte | motor complications | Clinical Medicine | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Anestesi och intensivvård | Anesthesiology and Intensive Care | Medicinska och farmaceutiska grundvetenskaper | Klinisk medicin | Neurovetenskaper
Journal Article
Experimental Neurology, ISSN 0014-4886, 06/2017, Volume 292, pp. 113 - 124
Journal Article